Sri Lanka receives 600,000 doses of China's Sinopharm vaccine: Official

The Chinese Sinopharm vaccine will be used on the Chinese workers currently in Sri Lanka.

Published - March 31, 2021 07:30 pm IST - Colombo

A nurse holds a vial of China's Sinopharm coronavirus disease (COVID-19) vaccine. File

A nurse holds a vial of China's Sinopharm coronavirus disease (COVID-19) vaccine. File

Sri Lanka on Wednesday received 600,000 doses of China’s Sinopharm vaccine that would be used for the vaccination of Chinese workers living in the island nation, a senior health official has said.

Sri Lankan President Gotabaya Rajapaksa accepted the vaccine from Chinese Ambassador Qi Zhenhong at the airport after the doses were flown in on Wednesday.

The vaccine was developed by Sinopharm’s Beijing Institute of Biological Products and the Wuhan Institute of Biological Products in China.

The Chinese Sinopharm vaccine will be used on the Chinese workers currently in Sri Lanka.

Around 200,000 Chinese workers are believed to be currently in Sri Lanka according to estimates.

“As per the Chinese government’s request, we will first vaccinate Chinese workers in Sri Lanka, most likely starting next week,” Chief Epidemiologist Dr Sudath Samaraweera said.

Although Sri Lanka’s National Medicine Regulatory Authority (NMRA) has approved the decision to bring in the Chinese vaccine, they have not approved for its emergency use as the World Health Organisation was yet to approve the Sinopharm vaccine for emergency use.

Sri Lanka till March 30 has vaccinated 913,219 people out of its 21 million population. India in January had donated 500,000 doses of anti-COVID vaccines to Sri Lanka.

India is one of the world's biggest drug-makers and an increasing number of countries have already approached it for procuring the coronavirus vaccines.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.